Floatz logo

Selinexor

Acute Myeloid Leukemia, Adult

Institute of Hematology & Blood Diseases Hospital, ChinaSmall moleculePhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

10 Active assets in the Acute Myeloid Leukemia, Adult cohort.

Asset / SponsorPhaseRating
Venetoclax
PETHEMA Foundation
Phase 3B
Fludarabine
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3B
Azacitidine
PETHEMA Foundation
Phase 3B
Cytosin-Arabinosid
First Affiliated Hospital of Zhejiang University
Phase 3B
Busulphan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 3B

View all 17 →

Same molecule, other indications

Selinexor is also rated in:

diffuse large B-cell lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →
mantle cell lymphomaDormant
BB
Indicative ·
70 / 100
View asset →
relapsed/refractory diffuse large B-cell lymphomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →